NFKB1 and cancer: For example, low LDL has been proposed to be associated with suppressed immunity, upregulated activity or responsiveness of the mevalonate pathway, and increased activity of nuclear transcription factor NF-κB [42], thus promoting the initiation and progression of cancer.